Showing results (201-210 of 350) with videos related to
Sort By:
Pageof 35
Journal of the American Academy of Dermatology|November 5, 2013
From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapiesJeremy Hugh, Abby S Van Voorhees, Rajiv I Nijhawan, et al.Journal of Drugs in Dermatology : JDD|August 16, 2017
Efficacy and Safety of Apremilast in Patients With Moderate Plaque Psoriasis With Lower BSA: Week 16 Results from the UNVEIL StudyBruce Strober, Jerry Bagel, Mark Lebwohl, et al.The Journal of Dermatological Treatment|October 21, 2016
Sustained response with ixekizumab treatment of moderate-to-severe psoriasis with scalp involvement: results from three phase 3 trials (UNCOVER-1, UNCOVER-2, UNCOVER-3)Kristian Reich, Craig Leonardi, Mark Lebwohl, et al.Journal of Drugs in Dermatology : JDD|May 19, 2005
Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient creamDebra Breneman, Alan B Fleischer, David Kaplan, et al.Journal of Drugs in Dermatology : JDD|June 5, 2023
Integrating Precision Medicine into Medical Dermatology Clinical Practice: An Expert Consensus PanelDanny Zakria, Nicholas Brownstone, April W Armstrong, et al.Journal of the American Academy of Dermatology|March 6, 2024
Mental health outcomes in patients with moderate to severe psoriasis treated with bimekizumab: Analysis of phase 2/3 randomized trialsAndrew Blauvelt, April Armstrong, Joseph F Merola, et al.International Journal of Dermatology|April 14, 2015
A consensus approach to improving patient adherence and persistence with topical treatment for actinic keratosisEggert Stockfleth, Ketty Peris, Carlos Guillen, et al.Advances in Therapy|September 23, 2020
PSO-LONG: Design of a Novel, 12-Month Clinical Trial of Topical, Proactive Maintenance with Twice-Weekly Cal/BD Foam in PsoriasisLinda Stein Gold, Javier Alonso-Llamazares, Jean-Philippe Lacour, et al.Journal of Managed Care & Specialty Pharmacy|April 27, 2026
AMCP Market Insights: Beyond skin deep on the role of managed care in moderate to severe atopic dermatitisBridget Flavin, Denise Wolff, Mike Abdo, et al.BMJ Open|April 22, 2019
Impact of psoriasis severity on patient-reported clinical symptoms, health-related quality of life and work productivity among US patients: real-world data from the Corrona Psoriasis RegistryBruce Strober, Jeffrey D Greenberg, Chitra Karki, et al.Pageof 35